alpha-1,3-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase I

Subscribe to Selected New Research on alpha-1,3-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase I

8 relevant articles (0 outcomes, 2 trials/studies) found for this Bio-Agent

Also Known As:

(1-2)-N-acetylglucosaminyltransferase I; GlcNAc transferase I; GlcNAc-TI; N-acetylglucosaminyltransferase I; UDP-GlcNAc alpha-3-D-mannoside beta1,2-N-acetylglucosaminyltransferase I; UDP-GlcNAc-alpha-Man-(1-3R) beta-(1-2)-N-acetylglucosaminyltransferase I; UDP-N-acetylglucosamine-3-mannoside 1,2-N-acetylglucosaminyltransferase I; UDP-N-acetylglucosamine-alpha-3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I; UDP-N-acetylglucosamine-alpha-mannoside beta-N-acetylglucosaminyltransferase; UDPGNAC-alpha-D-mannose beta-2-N-acetylglucosaminlytransferase I

Bio-Agent Context: Research Results

Enzymes and Coenzymes: 1

Enzymes: 24386

Transferases: 3172

Glycosyltransferases: 159

N-Acetylhexosaminyltransferases

N-Acetylglucosaminyltransferases: 14

alpha-1,3-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase I: 8

Related Diseases

1.	Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy) 04/28/1998 - "In this study, two glycosylation variants of the lysosomal enzyme N-acetylgalactosamine-4-sulphatase (4S) (the deficiency of which causes Mucopolysaccharidosis (MPS) type VI, (Maroteaux-Lamy syndrome) were made by expression of 4S cDNA in both wild type chinese hamster ovary (CHO-K1), and Lec1 (N-acetylglucosaminyltransferase I deficient CHO-K1) cells" Order ALL the reference details at left...
2.	Mucopolysaccharidoses 04/28/1998 - "In this study, two glycosylation variants of the lysosomal enzyme N-acetylgalactosamine-4-sulphatase (4S) (the deficiency of which causes Mucopolysaccharidosis (MPS) type VI, (Maroteaux-Lamy syndrome) were made by expression of 4S cDNA in both wild type chinese hamster ovary (CHO-K1), and Lec1 (N-acetylglucosaminyltransferase I deficient CHO-K1) cells" Order ALL the reference details at left...
3.	Hepatocellular Carcinoma (Hepatoma) 09/15/1981 - "Studies on UDP-N-acetylglucosamine : alpha-mannoside beta-N-acetylglucosaminyltransferase of rat liver and hepatomas." Order ALL the reference details at left...
4.	Teratocarcinoma 08/01/1992 - "A mouse cDNA clone previously isolated from an F9 teratocarcinoma cell library and shown to confer N-acetylglucosaminyltransferase I (GlcNAc-TI) activity on Lec1 Chinese hamster ovary (CHO) cell transfectants [Kumar, R., Yang,J., Larsen,R.D" Order ALL the reference details at left...
5.	Neoplasms (Cancer) 01/25/1991 - "In the SP1 tumor model, the metastatic sublines showed increased core 2 GlcNAc-transferase and GlcNAc-transferase V activities but no change in GlcNAc-transferase (i) activity, yet polylactosamine was increased in both O- and N-linked oligosaccharides" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Complementary DNA (cDNA)
2.	CAV protocol (CHO)
3.	Heparitin Sulfate (Heparan Sulfate)
4.	alpha-1,3-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase I
5.	Phosphatidylinositols (Phosphatidylinositol)
6.	Oligosaccharides
7.	polylactosamine
8.	UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferase
9.	beta- 1,3- galactosyl- O- glycosyl- glycoprotein beta-1,6-acetylglucosaminyl transferase
10.	ceramide glucosyltransferase

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>